Interim analysis of a phase II study of simultaneously integrated boost intensity modulated radiation therapy (SIB-IMRT) in combination with 5-FU and mitomycin-C among patients with locally advanced anal canal cancer.

C. Florescu,Justine Lequesne,Jean-Michel Grellard,Aurélie Parzy,Marie-Pierre Galais,Paul Lesueur,Marine Moreau,Marie Castera,Corentin Le Gallic,Anaïs Lelaidier,Mélanie Dos Santos,Bénédicte Clarisse

Interim analysis of a phase II study of simultaneously integrated boost intensity modulated radiation therapy (SIB-IMRT) in combination with 5-FU and mitomycin-C among patients with locally advanced anal canal cancer.

2021

C. Florescu
Justine Lequesne
Jean-Michel Grellard
Aurélie Parzy
Marie-Pierre Galais
Paul Lesueur
Marine Moreau
Marie Castera
Corentin Le Gallic
Anaïs Lelaidier
Mélanie Dos Santos
Bénédicte Clarisse

e15501Background: Concomitant radiochemotherapy is the standard treatment of locally advanced epidermoid anal canal carcinoma (EACC) but conventional radiotherapy (RT) frequently induces significan...

Keywords:

locally advanced
Medicine
Intensity-modulated radiation therapy
Phases of clinical research
Standard treatment
Mitomycin C
Interim analysis
Concomitant
Radiology
Anal Canal Cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations